BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2580551)

  • 1. Hormonal profiles in the follicular phase, luteal phase and first trimester of pregnancies arising from in-vitro fertilization.
    Yovich JL; Stanger JD; Yovich JM; Tuvik AI; Turner SR
    Br J Obstet Gynaecol; 1985 Apr; 92(4):374-84. PubMed ID: 2580551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment and hormonal treatment of the luteal phase of in vitro fertilization cycles.
    Yovich JL; Stanger JD; Yovich JM; Tuvik AI
    Aust N Z J Obstet Gynaecol; 1984 May; 24(2):125-30. PubMed ID: 6208891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.
    Balasch J; Creus M; Fábregues F; Carmona F; Casamitjana R; Peñarrubia J; Rivera F; Vanrell JA
    Gynecol Endocrinol; 1995 Mar; 9(1):51-8. PubMed ID: 7793300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary gonadotrophin secretion during the first weeks of pregnancy.
    Jeppsson S; Rannevik G; Thorell JI
    Acta Endocrinol (Copenh); 1977 May; 85(1):177-88. PubMed ID: 324219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid profiles during cycles with HCG stimulation of luteal function during in-vitro fertilization cycles.
    Blacker C; Cohen J; Castanier M; Debache C; Mandelbaum J; Plachot M; Scholler R
    Hum Reprod; 1986 Feb; 1(2):69-73. PubMed ID: 3104394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
    Sudik R; Fliess FR; Kunkel S
    Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
    Claman P; Domingo M; Leader A
    Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal and histological evaluation of the luteal phase after combined GnRH-agonist/gonadotrophin treatment for superovulation and luteal phase support in in-vitro fertilization.
    Balasch J; Jové I; Márquez M; Vanrell JA
    Hum Reprod; 1991 Aug; 6(7):914-7. PubMed ID: 1761657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxin in sera during the luteal phase of in-vitro fertilization cycles.
    Eddie LW; Martinez F; Healy DL; Sutton B; Bell RJ; Tregear GW
    Br J Obstet Gynaecol; 1990 Mar; 97(3):215-20. PubMed ID: 1692232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
    Ellenbogen A; David H; Libal Y; Ballas S
    Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone.
    Herman A; Raziel A; Strassburger D; Soffer Y; Bukovsky I; Ron-El R
    Hum Reprod; 1996 Jul; 11(7):1552-7. PubMed ID: 8671503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles.
    Golan A; Herman A; Soffer Y; Bukovsky I; Caspi E; Ron-El R
    Hum Reprod; 1993 Sep; 8(9):1372-5. PubMed ID: 8253920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy.
    Sealey JE; Itskovitz-Eldor J; Rubattu S; James GD; August P; Thaler I; Levron J; Laragh JH
    J Clin Endocrinol Metab; 1994 Jul; 79(1):258-64. PubMed ID: 8027239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.
    Valbuena D; Pellicer A; Guanes PP; Remohí J; Simón C
    Hum Reprod; 1997 Oct; 12(10):2118-22. PubMed ID: 9402265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism.
    Shoham Z; Howles CM; Zalel Y; Weissman A; Insler V
    Hum Reprod; 1994 Mar; 9(3):431-6. PubMed ID: 7516348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormone-binding globulin, oestradiol-17 beta, progesterone and testosterone at stimulation and after embryo transfer during in-vitro fertilization.
    Gustafson O; Lunell NO; Nylund L; Pousette A; Akerlöf E; Carlström K
    Hum Reprod; 1991 Sep; 6(8):1039-42. PubMed ID: 1806559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
    Yuen BH; Sy L; Cannon W
    Am J Obstet Gynecol; 1981 Jul; 140(6):629-35. PubMed ID: 6167169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.